Natera insider plans sale of 1,867 shares

Natera insider Michael Brophy has filed a Form 144 indicating an intent to sell 1,867 shares of Natera common stock.

Rhea-AI Filing Summary

Natera insider Michael Brophy has filed a Form 144 indicating an intent to sell 1,867 shares of Natera common stock. These shares were acquired on 01/27/2026 as restricted stock units from the issuer and are to be sold through Morgan Stanley Smith Barney LLC on or about 01/29/2026 on NASDAQ, with an aggregate market value of $440,481.31. Natera had 138,014,465 shares of common stock outstanding.

The filing also lists recent sales under a Rule 10b5-1 trading plan for Michael Brophy, including 1,176 shares sold on 01/28/2026 for $279,232.73 and 36,573 shares sold on 01/21/2026 for $8,875,115.05, as well as additional direct sales on 01/20–21/2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Natera (NTRA) disclose?

The filing shows insider Michael Brophy plans to sell 1,867 Natera common shares. These were acquired as restricted stock units on January 27, 2026, and are slated for sale through Morgan Stanley on or about January 29, 2026, on NASDAQ.

How many Natera (NTRA) shares is the insider planning to sell?

Michael Brophy plans to sell 1,867 Natera common shares. The filing values this planned sale at an aggregate market value of $440,481.31, with the transaction expected to occur around January 29, 2026, via Morgan Stanley on NASDAQ.

What recent Natera (NTRA) stock sales are listed for Michael Brophy?

The document lists several recent sales, including 1,176 shares on January 28, 2026, for $279,232.73 and 36,573 shares on January 21, 2026, for $8,875,115.05. Additional direct sales occurred on January 20 and 21, 2026, at disclosed gross proceeds.

How were the Natera (NTRA) shares to be sold originally acquired?

The 1,867 Natera shares to be sold were acquired as restricted stock units. They were granted by the issuer and acquired on January 27, 2026, with the same date shown as the payment date and the nature of payment noted as N/A.

What does the Natera (NTRA) Form 144 say about trading plans?

The filing references a Rule 10b5-1 sales plan for Michael Brophy. It also includes a representation that the person does not know any undisclosed material adverse information about Natera’s current or prospective operations when relying on such a trading plan.

How many Natera (NTRA) shares were outstanding according to the filing?

The Form 144 indicates that 138,014,465 shares of Natera common stock were outstanding. This figure serves as a baseline context relative to the 1,867 shares covered by the planned sale disclosed in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/29/2026 - 04:10 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001697362
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NATERA INC
SEC File Number	001-37478
Address of Issuer	13011 McCallen Pass, Bldg A Suite 100 Austin TEXAS 78753
Phone	6509809190
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL BROPHY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1867	440481.31	138014465	01/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2026	Restricted Stock Units	Issuer			1867	01/27/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for MICHAEL BROPHY 13011 McCallen Pass, Bldg A Suite 100 Austin TX 78753	COMMON	01/28/2026	1176	279232.73
10b5-1 Sales Plan for MICHAEL BROPHY 13011 McCallen Pass, Bldg A Suite 100 Austin TX 78753	COMMON	01/21/2026	36573	8875115.05
MICHAEL BROPHY 13011 McCallen Pass, Bldg A Suite 100 Austin TX 78753	Common	01/21/2026	602	141470.00
MICHAEL BROPHY 13011 McCallen Pass, Bldg A Suite 100 Austin TX 78753	Common	01/20/2026	23948	5621515.20

144: Remarks and Signature

Remarks
Date of Notice	01/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/14/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Brophy
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)